AnnaMed Rights Transfer AgreementAnnamed Rights Transfer Agreement • March 22nd, 2016 • Moleculin Biotech, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledMarch 22nd, 2016 Company Industry JurisdictionThis Rights Transfer Agreement (the “Agreement”) is made between Moleculin Biotech, Inc. (“MBI”), a Delaware Corporation, whose address is 1973 W Clay St, Houston, Texas 77019 and AnnaMed, Inc. (“AnnaMed”), a Delaware Corporation whose address is 1973 W Clay St, Houston, Texas 77019, on August 21, 2015 (“Effective Date”).